FTO, also known as the obesity gene or ALKBH9,[10] has been found to be aberrantly expressed in various cancers and associated with the risk of cancer development,[11] such as breast cancer,[12] thyroid cancer,[13] endometrial cancer,[14,15] pancreatic cancer,[16,17] and others. Here, FTO is linked to obesity due to melanocortin 4 receptor deficiency.